Exact Mass: 419.1667
Exact Mass Matches: 419.1667
Found 500 metabolites which its exact mass value is equals to given mass value 419.1667
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(14E)-2,11-dihydroxy-14-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
(-)-3-(4-(2-(Phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acid
SCD1 Inhibitor
Acorafloxacin
Glycine, L-gamma-glutamyl-2-(1-methyl-4-(nitrosothio)-4-piperidinyl)glycyl-
Perphenazine sulfoxide
5-[[1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl]amino]-3-methylimidazole-2,4-dione
Glandicoline B
An indole alkaloid with a tetracyclic skeleton that is isolated from Penicillium chrysogenum. CONFIDENCE Penicillium bissettii
1-(1,2-dimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-butan-2-one
3-O-Methyl-1,4,5,6-tetra-O-acetyl-2-deoxy-2(N-methyl-acetamido)-glucitol
5-(alpha-Glucosidomethyl)deoxycytidin|O5-D-glucopyranosyloxymethyl-2-deoxy-cytidine
(-)-8beta-(4-hydroxybenzyl)-2-methoxyberbin-3,10,11-triol|(-)-8beta-<4-hydroxybenzyl>-2-methoxyberbin-3,10,11-triol|8beta-form-8-(4-Hydroxybenzyl)-2-methoxy-3,10,11-berbintriol
Thr Asn Ala Asp
Ser Ala Gln Asp
MLS002153420-01!Pregnenolone sulfate sodium salt1852-38-6
Ala Ala Met Gln
Ala Ala Gln Met
Ala Cys Ile Asn
Ala Cys Leu Asn
Ala Cys Asn Ile
Ala Cys Asn Leu
Ala Cys Gln Val
Ala Cys Val Gln
Ala Asp Asn Thr
Ala Asp Gln Ser
Ala Asp Ser Gln
Ala Asp Thr Asn
Ala Glu Asn Ser
Ala Glu Ser Asn
Ala Gly Ser Trp
Ala Gly Trp Ser
Ala Ile Cys Asn
Ala Ile Asn Cys
Ala Leu Cys Asn
Ala Leu Asn Cys
Ala Met Ala Gln
Ala Met Gln Ala
Ala Asn Cys Ile
Ala Asn Cys Leu
Ala Asn Asp Thr
Ala Asn Glu Ser
Ala Asn Ile Cys
Ala Asn Leu Cys
Ala Asn Ser Glu
Ala Asn Thr Asp
Ala Gln Ala Met
Ala Gln Cys Val
Ala Gln Asp Ser
Ala Gln Met Ala
Ala Gln Ser Asp
Ala Gln Val Cys
Ala Ser Asp Gln
Ala Ser Glu Asn
Ala Ser Gly Trp
Ala Ser Asn Glu
Ala Ser Gln Asp
Ala Ser Trp Gly
Ala Thr Asp Asn
Ala Thr Asn Asp
Ala Val Cys Gln
Ala Val Gln Cys
Ala Trp Gly Ser
Ala Trp Ser Gly
Cys Ala Ile Asn
Cys Ala Leu Asn
Cys Ala Asn Ile
Cys Ala Asn Leu
Cys Ala Gln Val
Cys Ala Val Gln
Cys Gly Ile Gln
Cys Gly Leu Gln
Cys Gly Gln Ile
Cys Gly Gln Leu
Cys Ile Ala Asn
Cys Ile Gly Gln
Cys Ile Asn Ala
Cys Ile Gln Gly
Cys Leu Ala Asn
Cys Leu Gly Gln
Cys Leu Asn Ala
Cys Leu Gln Gly
Cys Asn Ala Ile
Cys Asn Ala Leu
Cys Asn Ile Ala
Cys Asn Leu Ala
Cys Asn Pro Ser
Cys Asn Ser Pro
Cys Pro Asn Ser
Cys Pro Ser Asn
Cys Gln Ala Val
Cys Gln Gly Ile
Cys Gln Gly Leu
Cys Gln Ile Gly
Cys Gln Leu Gly
Cys Gln Val Ala
Cys Ser Asn Pro
Cys Ser Pro Asn
Cys Val Ala Gln
Cys Val Gln Ala
Asp Ala Asn Thr
Asp Ala Gln Ser
Asp Ala Ser Gln
Asp Ala Thr Asn
Asp Gly Gln Thr
Asp Gly Thr Gln
Asp Asn Ala Thr
Asp Asn Thr Ala
Asp Gln Ala Ser
Asp Gln Gly Thr
Asp Gln Ser Ala
Asp Gln Thr Gly
Asp Ser Ala Gln
Asp Ser Gln Ala
Asp Thr Ala Asn
Asp Thr Gly Gln
Asp Thr Asn Ala
Asp Thr Gln Gly
Glu Ala Asn Ser
Glu Ala Ser Asn
Glu Gly Asn Thr
Glu Gly Gln Ser
Glu Gly Ser Gln
Glu Gly Thr Asn
Glu Asn Ala Ser
Glu Asn Gly Thr
Glu Asn Ser Ala
Glu Asn Thr Gly
Glu Gln Gly Ser
Glu Gln Ser Gly
Glu Ser Ala Asn
Glu Ser Gly Gln
Glu Ser Asn Ala
Glu Ser Gln Gly
Glu Thr Gly Asn
Glu Thr Asn Gly
Gly Ala Ser Trp
Gly Ala Trp Ser
Gly Cys Ile Gln
Gly Cys Leu Gln
Gly Cys Gln Ile
Gly Cys Gln Leu
Gly Asp Gln Thr
Gly Asp Thr Gln
Gly Glu Asn Thr
Gly Glu Gln Ser
Gly Glu Ser Gln
Gly Glu Thr Asn
Gly Gly Thr Trp
Gly Gly Trp Thr
Gly Ile Cys Gln
Gly Ile Gln Cys
Gly Leu Cys Gln
Gly Leu Gln Cys
Gly Met Asn Val
Gly Met Val Asn
Gly Asn Glu Thr
Gly Asn Met Val
Gly Asn Thr Glu
Gly Asn Val Met
Gly Gln Cys Ile
Gly Gln Cys Leu
Gly Gln Asp Thr
Gly Gln Glu Ser
Gly Gln Ile Cys
Gly Gln Leu Cys
Gly Gln Ser Glu
Gly Gln Thr Asp
Gly Ser Ala Trp
Gly Ser Glu Gln
Gly Ser Gln Glu
Gly Ser Trp Ala
Gly Thr Asp Gln
Gly Thr Glu Asn
Gly Thr Gly Trp
Gly Thr Asn Glu
Gly Thr Gln Asp
Gly Thr Trp Gly
Gly Val Met Asn
Gly Val Asn Met
Gly Trp Ala Ser
Gly Trp Gly Thr
Gly Trp Ser Ala
Gly Trp Thr Gly
Ile Ala Cys Asn
Ile Ala Asn Cys
Ile Cys Ala Asn
Ile Cys Gly Gln
Ile Cys Asn Ala
Ile Cys Gln Gly
Ile Gly Cys Gln
Ile Gly Gln Cys
Ile Asn Ala Cys
Ile Asn Cys Ala
Ile Gln Cys Gly
Ile Gln Gly Cys
Leu Ala Cys Asn
Leu Ala Asn Cys
Leu Cys Ala Asn
Leu Cys Gly Gln
Leu Cys Asn Ala
Leu Cys Gln Gly
Leu Gly Cys Gln
Leu Gly Gln Cys
Leu Asn Ala Cys
Leu Asn Cys Ala
Leu Gln Cys Gly
Leu Gln Gly Cys
Met Ala Ala Gln
Met Ala Gln Ala
Met Gly Asn Val
Met Gly Val Asn
Met Asn Gly Val
Met Asn Val Gly
Met Gln Ala Ala
Met Val Gly Asn
Met Val Asn Gly
Asn Ala Cys Ile
Asn Ala Cys Leu
Asn Ala Asp Thr
Asn Ala Glu Ser
Asn Ala Ile Cys
Asn Ala Leu Cys
Asn Ala Ser Glu
Asn Ala Thr Asp
Asn Cys Ala Ile
Asn Cys Ala Leu
Asn Cys Ile Ala
Asn Cys Leu Ala
Asn Cys Pro Ser
Asn Cys Ser Pro
Asn Asp Ala Thr
Asn Asp Thr Ala
Asn Glu Ala Ser
Asn Glu Gly Thr
Asn Glu Ser Ala
Asn Glu Thr Gly
Asn Gly Glu Thr
Asn Gly Met Val
Asn Gly Thr Glu
Asn Gly Val Met
Asn Ile Ala Cys
Asn Ile Cys Ala
Asn Leu Ala Cys
Asn Leu Cys Ala
Asn Met Gly Val
Asn Met Val Gly
Asn Pro Cys Ser
Asn Pro Ser Cys
Asn Ser Ala Glu
Asn Ser Cys Pro
Asn Ser Glu Ala
Asn Ser Pro Cys
Asn Thr Ala Asp
Asn Thr Asp Ala
Asn Thr Glu Gly
Asn Thr Gly Glu
Asn Val Gly Met
Asn Val Met Gly
Pro Cys Asn Ser
Pro Cys Ser Asn
Pro Asn Cys Ser
Pro Asn Ser Cys
Pro Ser Cys Asn
Pro Ser Asn Cys
Gln Ala Ala Met
Gln Ala Cys Val
Gln Ala Asp Ser
Gln Ala Met Ala
Gln Ala Ser Asp
Gln Ala Val Cys
Gln Cys Ala Val
Gln Cys Gly Ile
Gln Cys Gly Leu
Gln Cys Ile Gly
Gln Cys Leu Gly
Gln Cys Val Ala
Gln Asp Ala Ser
Gln Asp Gly Thr
Gln Asp Ser Ala
Gln Asp Thr Gly
Gln Glu Gly Ser
Gln Glu Ser Gly
Gln Gly Cys Ile
Gln Gly Cys Leu
Gln Gly Asp Thr
Gln Gly Glu Ser
Gln Gly Ile Cys
Gln Gly Leu Cys
Gln Gly Ser Glu
Gln Gly Thr Asp
Gln Ile Cys Gly
Gln Ile Gly Cys
Gln Leu Cys Gly
Gln Leu Gly Cys
Gln Met Ala Ala
Gln Ser Ala Asp
Gln Ser Asp Ala
Gln Ser Glu Gly
Gln Ser Gly Glu
Gln Thr Asp Gly
Gln Thr Gly Asp
Gln Val Ala Cys
Gln Val Cys Ala
Ser Ala Asp Gln
Ser Ala Glu Asn
Ser Ala Gly Trp
Ser Ala Asn Glu
Ser Ala Trp Gly
Ser Cys Asn Pro
Ser Cys Pro Asn
Ser Asp Ala Gln
Ser Asp Gln Ala
Ser Glu Ala Asn
Ser Glu Gly Gln
Ser Glu Asn Ala
Ser Glu Gln Gly
Ser Gly Ala Trp
Ser Gly Glu Gln
Ser Gly Gln Glu
Ser Gly Trp Ala
Ser Asn Ala Glu
Ser Asn Cys Pro
Ser Asn Glu Ala
Ser Asn Pro Cys
Ser Pro Cys Asn
Ser Pro Asn Cys
Ser Gln Ala Asp
Ser Gln Asp Ala
Ser Gln Glu Gly
Ser Gln Gly Glu
Ser Trp Ala Gly
Ser Trp Gly Ala
Thr Ala Asp Asn
Thr Ala Asn Asp
Thr Asp Ala Asn
Thr Asp Gly Gln
Thr Asp Asn Ala
Thr Asp Gln Gly
Thr Glu Gly Asn
Thr Glu Asn Gly
Thr Gly Asp Gln
Thr Gly Glu Asn
Thr Gly Gly Trp
Thr Gly Asn Glu
Thr Gly Gln Asp
Thr Gly Trp Gly
Thr Asn Asp Ala
Thr Asn Glu Gly
Thr Asn Gly Glu
Thr Gln Asp Gly
Thr Gln Gly Asp
Thr Trp Gly Gly
Val Ala Cys Gln
Val Ala Gln Cys
Val Cys Ala Gln
Val Cys Gln Ala
Val Gly Met Asn
Val Gly Asn Met
Val Met Gly Asn
Val Met Asn Gly
Val Asn Gly Met
Val Asn Met Gly
Val Gln Ala Cys
Val Gln Cys Ala
Trp Ala Gly Ser
Trp Ala Ser Gly
Trp Gly Ala Ser
Trp Gly Gly Thr
Trp Gly Ser Ala
Trp Gly Thr Gly
Trp Ser Ala Gly
Trp Ser Gly Ala
Trp Thr Gly Gly
(3R,4S)-3-Azetidinepropanoic acid,1-(4-fluorophenyl)-2-oxo-4[4(phenylmethoxy)phenyl]-methyl ester
3-methyl-5-phenylmethoxy-2-(4-phenylmethoxyphenyl)-1H-indole
N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)PYRAZINE-2-CARBOXAMIDE
SCD1 inhibitor
CHIR-124
Ragaglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
Bavisant dihydrochloride
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Bavisant dihydrochloride hydrate (JNJ31001074AAC) is an orally active, potent, brain-penetrating and highly selective antagonist of the histamine H3 receptor. Bavisant dihydrochloride hydrate can be used for attention-deficit hyperactivity disorder (ADHD) research[1][2][3].
4-[(4-Fluorophenyl)-(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)methyl]-1-piperazinecarboxylic acid ethyl ester
(1S,2R,5S)-5-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8H)-YL]-2-(2,4,5-trifluorophenyl)cyclohexanamine
(2r)-4-(2-Benzoyl-1,2-Diazepan-1-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)butan-2-Amine
(2,2-Diphosphonoethyl)(Dodecyl)dimethylphosphonium
3-[5-[(Z)-[(5Z)-4-ethenyl-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-3-methylpyrrol-2-ylidene]methyl]-2-hydroxy-4-methyl-1H-pyrrol-3-yl]propanoic acid
7-[(3Z)-3-(2-amino-1-fluoroethylidene)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-(1-piperidinylmethyl)purine-2,6-dione
2-ethyl 4-isopropyl 5-{[3-(1,5-dimethyl-1H-pyrazol-4-yl)acryloyl]amino}-3-methyl-2,4-thiophenedicarboxylate
2-[[2-(3,4-Dimethoxyphenyl)-5-methyl-4-oxazolyl]methylthio]-1-(4-ethyl-1-piperazinyl)ethanone
N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]-2-(3-methylphenoxy)acetamide
3-(Methoxymethyl)-2-benzofurancarboxylic acid [4-amino-6-(2-methylanilino)-1,3,5-triazin-2-yl]methyl ester
4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide
3-[1-[[1-(4-Methoxyphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
N-cycloheptyl-2-[[2-(1,3-dioxo-2-isoindolyl)-1-oxoethyl]amino]benzamide
N-(5-tert-butyl-2-phenyl-3-pyrazolyl)-2-[(6-methyl-1H-benzimidazol-2-yl)thio]acetamide
N-[2-[(1,3-benzodioxol-5-ylmethylamino)-oxomethyl]phenyl]-2-ethoxy-3-pyridinecarboxamide
6-(3,4-Dimethoxyphenyl)-4-oxo-3-phenyl-1,5,6,7-tetrahydroindole-2-carboxylic acid ethyl ester
1-(2-furanylmethyl)-3-(3-methoxyphenyl)-1-[2-(2-methyl-1H-indol-3-yl)ethyl]thiourea
Butyl 3-amino-12,12-dimethyl-8-morpholin-4-yl-11-oxa-5-thia-7-azatricyclo[7.4.0.02,6]trideca-1(9),2(6),3,7-tetraene-4-carboxylate
2-(1H-benzimidazol-2-yl)-N-(4-phenylmethoxyphenyl)benzamide
N-[(2S,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-lysine
A N(6)-acyl-L-lysine arising from reductive N-alkylation of N(6)-acetyl-L-lysine by pyridoxal-5-phosphate.
N-[(E)-(4-hydroxy-3-methoxyphenyl)methylideneamino]-2-oxo-3-spiro[4H-isoquinoline-3,1-cyclopentane]-1-ylpropanamide
sodium;[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
ascofuranone(1-)
A phenolate anion that is the conjugate base of ascofuranone resulting from the deprotonation of the 4-hydroxy group. Major species at pH 7.3.
hnRNPK-IN-1
hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities[1].